Testing and Monitoring

Displaying 11 - 20 of 136

Transparent organs reveal metastasis in real time

Transparent organs reveal metastasis in real time
Scientists at the University of Tokyo’s Graduate School of Medicine have developed a method of imaging, published in the journal Cell Reports, that shows metastasis in real time, at the level of individual cells. The technique relies on modified cancer cells that glow and a chemical cocktail that turns organs transparent, making the fluorescent signals emitted by the modified cells easier to see. This can offer a better understanding of metastasis that researchers could use to develop better drugs.
6th July 2017

Nevisense system tests lesions before biopsy for melanoma

Nevisense system tests lesions before biopsy for melanoma
SciBase won FDA approval to introduce its Nevisense system to help dermatologists assess suspect cutaneous lesions that may be melanoma tumours. Unlike many technologies that have been attempted to characterise cancerous lesions, this one uses electrical impedance rather than optical methods. The system delivers electric current at different frequencies through the lesion using a pen-like device.
6th July 2017

Biomedical startup obtains CE mark for blood analysis platform

Biomedical startup obtains CE mark for blood analysis platform
Finnish biomedical startup Nightingale Health has announced CE marking for its blood biomarker analysis platform. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine and glucose in the EU region. Nightingale’s goal is to bring dozens of biomarkers included in the analysis platform gradually available for clinical use within the next year. The obtained CE mark is a step towards the company’s aim, enabling better prediction and targeted care for chronic diseases.
5th July 2017


Left Ventricular Assist Device set for 2018 clinical trials

Left Ventricular Assist Device set for 2018 clinical trials
Working with the University of Swansea, Calon Cardio, a Welsh firm, has created the first UK-developed Left Ventricular Assist Device (LVAD). The MiniVAD is scheduled to begin a 50 patient clinical trial in late 2018, with a full clinical rollout planned for 2020. Calon Cardio’s miniature implantable heart pump is used to treat advanced chronic heart failure, with the LVAD augmenting the weakened heart and providing adequate blood perfusion to the rest of the body.
28th June 2017

Boosting quality of patient MRIs unveil stroke outcomes

Boosting quality of patient MRIs unveil stroke outcomes
  People who suffer a stroke often undergo a brain scan at the hospital, allowing doctors to determine the location and extent of the damage. Researchers who study the effects of strokes would love to be able to analyse these images, but the resolution is often too low for many analyses.
23rd June 2017

How electrical interference can cause pacemaker issues

How electrical interference can cause pacemaker issues
During the French Revolution, beheading was the preferred method of execution. The guillotine was used for thousands of executions, meaning there was no shortage of experimental material for biologist Marie Francois Bichat. Bichat tested the electrical stimulation of hearts, which was instrumental in the development of the modern day pacemaker. Nowadays, pacemakers are commonly used to maintain a regular heart rate.
22nd June 2017

Human tissue model to test colon cancer drugs

Human tissue model to test colon cancer drugs
The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease. The discovery also overcomes a long-standing challenge of using mice to research this form of cancer, as they do not typically develop the disease.
21st June 2017

Laser imaging 'bowl' gives instant test for breast cancer

Laser imaging 'bowl' gives instant test for breast cancer
In a bid to make the world's first while-you-wait test for breast cancer, European scientists are developing a comfortable hemispherical bowl lined with laser sources and ultrasound detectors with the potential to reduce the stages in spotting the disease into a single appointment. Current breast cancer diagnosis can be distressing and painful over a number of weeks.
21st June 2017

Micra pacemaker goes on a space flight

Micra pacemaker goes on a space flight
These days astronauts are some of the healthiest and physically robust individuals that NASA can get a hold of. But one day we may see all kinds of people going to space, even those with heart conditions. Shelbi Klingsporn, a Nebraska high school student had the idea to test whether an existing pacemaker is able to handle the vibrations, radiation, and weightlessness of space to get a sense of whether pacemakers have a future in the final frontier.
19th June 2017

Pacemakers get 3T MR-conditional approval in Europe

Pacemakers get 3T MR-conditional approval in Europe
BIOTRONIK has received CE approval for 3T full-body scans (FBS) with its latest range of MR conditional pacemaker systems. Patients implanted with single- and dual-chamber pacemakers from the Edora/Evity/Enitra series can now benefit from ultra-high field MRI scans without any restrictions on the scanned body area. BIOTRONIK’s ProMRI pacemaker portfolio was previously approved for 1.5T FBS. With 3T FBS compatibility, radiologists can offer pacemaker patients additional high-quality imaging options.
16th June 2017


Testing and Monitoring documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham
Productronica India 2017
14th September 2017
India Pragati Maidan, New Delhi
Industry of Things World 2017
18th September 2017
Germany Berlin Congress Center